Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer
N. Iwai(Kyoto Prefectural University of Medicine), Yoshito Itoh(Fukui-ken Saiseikai Hospital), Hiroaki Yasuda(Kyoto Prefectural University of Medicine), Tasuku Hara(Fukuyama City Hospital), Takashi Okuda(Nara City Hospital), Osamu Dohi(Kyoto Prefectural University of Medicine), Chie Hattori(Fukuyama City Hospital), Junichi Sakagami(SHOWA Medical University), Toshiyuki Komaki(Fukuyama City Hospital), Taishi Harada(Fukuyama City Hospital), Keizo Kagawa(Fukuyama City Hospital), Hiroaki Sakai(Kyoto University), Tomoya Ohara(Fukuyama City Hospital), Kohei Oka(Fukuyama City Hospital), Toshifumi Tsuji(Fukuyama City Hospital), Masashi Taniguchi(Fukuyama City Hospital)
Cited by 7
Related Papers
DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
|Circulation|1994|235
Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression
|Biochemical and Biophysical Research Communications|1991|189
Isolation of preferentially expressed genes in the kidneys of hypertensive rats.
|Hypertension|1991|168
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040
|Hepatology International|2021|151
The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
|Oncology Reports|2017|145